CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) was the target of a large increase in short interest in May. As of May 31st, there was short interest totalling 11,270,000 shares, an increase of 39.5% from the May 15th total of 8,080,000 shares. Based on an average trading volume of 5,510,000 shares, the short-interest ratio is […]
CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) was the target of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 11,270,000 shares, an increase of 39.5% from the May 15th total of 8,080,000 shares. Based on an average daily trading volume, of 5,510,000 shares, […]
StockNews.com initiated coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a research report report published on Saturday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other research firms also recently weighed in on CTIC. TD Cowen dropped their price target on shares of CTI BioPharma from […]
StockNews.com assumed coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a report published on Friday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other analysts have also recently issued reports on CTIC. Needham & Company LLC cut CTI BioPharma from a buy rating to a hold […]
StockNews.com assumed coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a research report sent to investors on Thursday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other analysts have also issued research reports about the company. Lake Street Capital lowered CTI BioPharma from a buy rating to a […]